All MACs to cover Osiris Therapeutics’ Grafix for wound care: 3 points

All eight Medicare Administrative Contractors have confirmed coverage for the treatment of chronic wounds with Osiris Therapeutics’ Grafix.

Advertisement

Here are three points:

 

1. Grafix is a cryopreserved placental membrane comprised of an extracellular matrix rich in collagen, growth factors, fibroblasts, mesenchymal stem cells and epithelial cells native to the tissue.

 

2. The eight MACs provide Medicare benefits to more than 54 million beneficiaries.

 

3. Osiris Therapeutics focuses on researching, developing and marketing cellular regenerative medicine products for the orthopedics, sports medicine and wound care markets.

 

More articles on devices:
Amedica, J&J, Stryker & more: 18 key notes
Smith & Nephew CEO Olivier Bohuon has cancer—But will remain on the job
North America leads global neurosurgery market: 5 points

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

  • Since March 25, there have been two key developments in lawsuits involving spine medtech companies. 1. The U.S. Court of…

  • The highest-paid CFOs at spine and orthopedic medtech companies saw total compensation reaching in the mid-single digits and beyond. Here…

Advertisement

Comments are closed.